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Abstract 29 
Replacement of fish oil with sustainable alternatives, such as vegetable oil, in aquaculture diets has to 30 
be achieved without compromising the nutritional quality, in terms of n-3 highly unsaturated fatty acid 31 
(HUFA) content, of the product. This may be possible if the level of replacement is not too high and oil 32 
blends are chosen carefully but, if high levels of fish oil are substituted, a fish oil finishing diet prior to 33 
harvest would be required to restore n-3HUFA. However, a decontaminated fish oil would be required 34 
to avoid increasing undesirable contaminants. Here we test the hypotheses that blending of rapeseed 35 
and soybean oils with southern hemisphere fish oil will have a low impact upon tissue n-3HUFA 36 
levels, and that decontamination of fish oil will have no major effect on the nutritional quality of fish 37 
oil as a feed ingredient for Atlantic salmon. Salmon (initial weight ~0.8 kg) were fed for 10 weeks with 38 
diets in which 60% of fish oil was replaced with blends of soybean, rapeseed and southern hemisphere 39 
fish oil (SVO) or 100% decontaminated northern fish oil (DFO) in comparison with a standard northern 40 
fish oil diet (FO). Decontamination of the oil was a two-step procedure that included treatment with 41 
activated carbon followed by thin film deodorisation. Growth performance and feed efficiency were 42 
unaffected by either the SVO or DFO diets despite these having lower gross nutrient and fatty acid 43 
digestibilities than the FO diet.  There were also no effects on the gross composition of the fish. Liver 44 
and, to a lesser extent flesh, lipid levels were lower in fish fed the SVO blends, due to lower 45 
proportions of neutral lipids, specifically triacylglycerol. Tissue lipid levels were not affected in fish 46 
fed the DFO diet. Reflecting the diet, flesh eicosapentaenoic acid (EPA) and total n-3 fatty acids were 47 
higher, and 18:1n-9 lower, in fish fed DFO than FO, whereas there were no differences in liver fatty 48 
acid compositions. Flesh EPA levels were only slightly reduced from about 6% to 5% although 49 
docosahexaenoic acid (DHA) was reduced more severely from around 13% to about 7% in fish fed the 50 
SVO diets. In contrast, the liver fatty acid compositions showed higher levels of n-3 HUFA, with DHA 51 
only reduced from 21% to about 18% and EPA increased from under 8% to 9-10% in fish fed the SVO 52 
diets. The evidence suggested that increased liver EPA (and arachidonic acid) was not simply retention, 53 
but also conversion of dietary 18:3n-3 and 18:2n-6. Increased HUFA synthesis was supported by 54 
increased hepatic expression of fatty acyl desaturases in fish fed the SVO diets. Flesh n-3HUFA levels 55 
and desaturase expression was significantly higher in fish fed soybean oil than in fish fed rapeseed oil. 56 
In conclusion, partial replacement of fish oil with blends of vegetable oils and southern hemisphere fish 57 
oil had minimal impact on HUFA levels in liver, but a greater effect on flesh HUFA levels. Despite 58 
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lower apparent digestibility, decontamination of fish oil did not significantly impact its nutritional 59 
quality for salmon. 60 
61 
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1. Introduction 61 
Fish are the most important source of the n-3 highly unsaturated fatty acids (HUFA) in the human diet 62 
that have been shown to have beneficial effects in a number of inflammatory and pathological 63 
conditions, including cardiovascular and neurological diseases (Brower et al., 2006; Givens and Gibbs, 64 
2006; Eilander et al., 2007).  Demand for fish products is increasing such that an increasing proportion 65 
of fish are derived from aquaculture production (Tidwell and Allan, 2002). Lipids are a major source of 66 
energy, and fish oils are the main source of dietary lipid, providing essential polyunsaturated fatty acids 67 
(PUFA), specifically the HUFA, eicosapentaenoic (EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-68 
3) acids, to promote normal growth and development (Sargent et al., 2002). However, the composition 69 
of fish oils varies among sources both in terms of nutrition (n-3HUFA) and also undesirable 70 
contaminants (e.g. persistent organic pollutants, POPs) that may affect human health. Fish oil supplies 71 
are finite and at their sustainable limit (FAO, 2006) and so continued aquaculture development requires 72 
replacement of fish oil with alternative nutritionally suitable and sustainable oils (Tacon, 2004; Pike, 73 
2005).  74 
    Presently, vegetable oils (VOs) are the only viable, cost competitive alternative lipid source for 75 
aquaculture diets and a number have been used as partial and complete replacements for fish oil (Bell 76 
et al., 2005a). As VOs are devoid of n-3HUFA, they have a major impact on the fatty acid composition 77 
of the final products if added at high inclusion levels. For that reason, some studies have investigated 78 
the use of “finishing diets” containing fish oil to restore levels of n-3HUFA in the flesh (Bell et al., 79 
2003a,b, 2004; Robin et al., 2003; Caballero et al., 2004; Izquierdo et al., 2005; Mourente et al., 2005; 80 
Torstensen et al., 2005; Mourente and Bell, 2006). However, the use of FO finishing diets has a 81 
conceptual drawback in that, in addition to adding back the valuable and highly desirable n-3HUFA, it 82 
could be challenged as a viable solution due to the potential for increasing POPs in a previously low 83 
contaminant load product (Bell et al., 2005a).  Although the content of POPs in farmed fish, including 84 
salmon, has been shown to be below all national and international limits (FDA, UK and European FSA, 85 
WHO, EU) (Bell et al., 2005a,b; Berntssen et al., 2005), their presence in farmed fish, especially 86 
salmon, has received some negative reporting (Hites et al., 2004).  To avoid this conundrum, it may be 87 
highly desirable to formulate finishing diets with decontaminated fish oil. Therefore, although 88 
availability of decontaminated fish oil is still limited, market demand for this oil may change this 89 
situation in the near future, and so it is important to evaluate potential effects of the decontamination 90 
process on the nutritional quality of the oil and how it may affect growth performance and product 91 
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quality. 92 
     At lower inclusion levels, dietary VOs have correspondingly less impact on flesh fatty acid 93 
compositions (Robin et al., 2003). Therefore, an alternative to finishing diets would be the use of lower 94 
levels of fish oil substitution, particularly if the oil blends used are carefully chosen to limit HUFA 95 
reduction (Torstensen et al., 2004).  For instance, southern hemisphere fish oils contain higher levels of 96 
n-3HUFA, especially EPA, and so can deliver similar levels of n-3HUFA at lower inclusion levels than 97 
the northern hemisphere fish oils traditionally used in salmonid diets (Sargent et al., 2002).  On the 98 
other hand, the southern fish oils are also lower in C20 and C22 monoenes, traditionally regarded as 99 
excellent energy sources for salmonids (Tocher, 2003) as well as containing higher levels of saturated 100 
fatty acids (Karalazos et al., 2007). Different VOs also have contrasting nutritional and economic 101 
qualities. Rapeseed oil is nutritionally balanced but is relatively expensive, whereas soybean oil is 102 
readily available and its price favourable, although it contains high levels of 18:2n-6, which limits the 103 
use of this oil due to greater reduction of the n-3/n-6 ratio in the product. In addition, EU legislations 104 
limit the commercial use of soybean oils to non-GM products containing a maximum of 1.0 mg kg-1 105 
endosulfane (pesticide residue).  106 
   In the present study, we test two hypotheses.  Firstly, that blending of rapeseed and soybean oils with 107 
southern hemisphere fish oil is a strategy that may result in lower impact upon tissue n-3HUFA levels 108 
in Atlantic salmon.  Secondly, that the decontamination (stripping) of fish oil will have no major effect 109 
on the nutritional quality of the fish oil as a feed ingredient for Atlantic salmon. Specifically, we 110 
investigated the effects of replacement of northern hemisphere fish oil by decontaminated northern fish 111 
oil and blends of southern hemisphere fish oil with rapeseed and soybean oils on growth performance 112 
and composition of Atlantic salmon. The use of decontaminated fish oil and VO substitution are also 113 
two alternative methods for reducing contaminant loads in the flesh of farmed Atlantic salmon.  The 114 
effects of these diets on flesh contaminant levels will be reported separately. 115 
 116 
2. Materials and methods 117 
 118 
2.1. Diets and animals 119 
Five diets (9 mm pellets) with the same basal composition but coated with five different oils were 120 
prepared at the BioMar TechCentre, Brande, Denmark. The diets were formulated to satisfy the 121 
nutritional requirements of salmonid fish (National Research Council 1993), and to contain 33% crude 122 
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protein and 34% crude lipid (Table 1). The northern hemisphere and decontaminated northern 123 
hemisphere fish oils were both sprat (Sprattus sprattus) and were obtained from FF Skagen, Skagen, 124 
Denmark. Decontamination of the oil was a two-step procedure that included treatment with activated 125 
carbon followed by thin film deodorisation to remove persistant organic pollutants. The southern 126 
hemisphere fish oil was from anchovetta (Engraulis rigens), and the rapeseed (low in erucic acid and 127 
glycosinolates) and soybean oils were both non-GM, degummed quality. The diets produced were 128 
100% northern fish oil (FO) as control, 100% decontaminated northern fish oil (DFO), and three blends 129 
of the VOs with southern hemisphere fish oil (collectively termed the SVO diets), specifically 40% 130 
southern fish oil/60% rapeseed oil (SRO), 40% southern fish oil/30% rapeseed oil/30% soybean oil 131 
(SRO/SO) and 40% southern fish oil/60% soybean oil (SSO). The fatty acid compositions of the 132 
experimental diets are given in Table 2. Atlantic salmon (Salmo salar L) of initial mean weight 0.78 ± 133 
0.01 kg were fed for 10 weeks one of the five diets in triplicate 5 × 5 × 5 m net pens (n =3 per 134 
treatment) with 120 fish/pen at Fjord Research Station, Dønna, Norway. The experiment was 135 
performed between July and October under natural photoperiod and when the mean seawater 136 
temperature was 11.5 ± 2.7 oC and salinity was 31.9 ± 0.8 ‰. Feed was supplied manually to apparent 137 
satiation twice a day with waste feed collection via an up-lift system.  Feed fed, waste feed and the 138 
resulting net feed intake were registered daily, as were any mortalities.  139 
 140 
2.2. Sampling protocols  141 
 142 
At the start and end of the trial, all the fish in each pen were bulk weighed. At the end of the trial, 6 fish 143 
per pen (18 per dietary treatment) were anaesthetised by metacaine (50 mg/l) and faeces collected by 144 
stripping.  Fish were then killed by a blow to the head and samples taken for compositional analyses.  145 
The gut cavity was opened on three fish per pen and any remaining contents of the intestine removed 146 
before each whole fish was cut into pieces and minced thoroughly and samples collected and stored at -147 
20 oC prior to proximate analyses.  The remaining three fish per pen were used for lipid and fatty acid 148 
analyses.  Flesh was sampled by taking the Norwegian Quality Cut (NQC) and immediately frozen at -149 
20 oC. Livers were dissected and three samples collected.  Approximately 0.5 g of liver was placed into 150 
a glass vial containing ice-cold chloroform/methanol (2:1, by vol.) and then stored at -20 oC prior to 151 
lipid class analysis.  A further piece of < 0.5 g was collected into a microcentrifuge tube for RNA 152 
analysis, and the remaining liver for fatty acid analysis placed in a plastic test tube, with both these 153 
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samples being immediately frozen in liquid nitrogen before being stored at -70 oC and -20 oC, 154 
respectively, prior to analyses. 155 
 156 
2.3. Proximate analyses 157 
 158 
 The proximate compositions of diets and minced whole fish were determined by standard procedures 159 
(AOAC, 2000). Thus, moisture content was determined after drying to constant weight in an oven at 160 
105 oC for 24h.  The samples were then rigorously blended into a homogeneous crumb/meal and used 161 
for determination of diet or whole body lipid, protein and ash contents.  Lipid content in 1 g samples of 162 
dried crumb was determined using the Soxhlet method with extraction in petroleum ether at 120 oC 163 
(Avanti Soxtec 2050 Auto Extraction apparatus; Foss, Warrington, UK).  Crude protein content (N x 164 
6.25) was determined in the crumb using the automated Kjeldahl method (Tecator Kjeltec Auto 1030 165 
Analyser; Foss, Warrington, UK). Ash contents were determined after heating portions of the crumb at 166 
160 oC for 48 h. The gross energy content of the diets was determined by Bomb Calorimetry 167 
(Gallenkamp Autobomb System).  168 
 169 
2.4. Pigment analyses 170 
 171 
Astaxanthin was extracted from salmon muscle largely by the method of Barua et al. (1993). Tissue 172 
samples were homogenised in 5 ml of absolute ethanol and 5 ml of ethyl acetate using an Ultra-Turrax 173 
tissue disrupter. The homogenate was centrifuged (1000 x g, 5 min) and the supernatant removed to a 174 
stoppered glass tube. The pellet was re-homogenised in 5 ml of ethyl acetate, centrifuged, and the 175 
supernatant combined with the first supernatant. Finally, the pellet was re-homogenised in 10 ml of 176 
hexane, centrifuged, and the supernatant combined with the pooled supernatant. The pooled 177 
supernatant was dried under N2 and vacuum desiccated for 2 h before dissolving the residue in 2 ml of 178 
hexane containing 0.2% (w/v) BHT. Measurement of astaxanthin was carried out using a 5-µm 179 
SYNERGI 4µ MAX-RP column (4.6 x 150 mm, Phenomenex, Macclesfield, UK). The 180 
chromatographic system was equipped with a Waters Model 501 pump and astaxanthin was detected 181 
at 470 nm using a Waters 490E multiwavelength UV/vis detector (Millipore UK, Watford). An 182 
isocratic solvent system was used containing acetonitrile/methanol (95:5, v/v) at a flow rate of 0.8 183 
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ml/min. Astaxanthin was detected at 470 nm and quantified using an external standard of astaxanthin 184 
obtained from Roche (Heanor, UK). 185 
      Carotenoid in diets was extracted using the same solvent mixtures as described above but after 186 
enzymatic digestion with Maxatase (International Biosynthetics, Rijswijk, Netherlands). Portions of 187 
ground diet (1g) were mixed with 10 ml water and 110 mg Maxatase in a 50 ml stoppered glass tube 188 
followed by incubation in a water bath at 50oC for 30 min.  Measurement of diet carotenoids was 189 
carried out using a 5-µm Lichrosorb 5µ Silica 60 column (4.0 x 125 mm, Phenomenex, Macclesfield, 190 
U.K.). The chromatographic system was equipped with a Waters Model 510 pump and astaxanthin 191 
was detected at 470 nm using a Waters 486 multiwavelength UV/vis detector (Millipore U.K., 192 
Watford). An isocratic solvent system was used containing iso-hexane/acetone (86:14, v/v) at a flow 193 
rate 1 ml/min.  194 
2.5. Apparent nutrient digestibility 195 
 196 
Yttrium oxide (Y2O3) was determined by inductively coupled plasma-optical emission spectrometry 197 
(ICP-OES). The diet (0.2-0.5g) or faeces (0.1g) were weighed into pre-cleaned beakers and 4 ml of 198 
concentrated nitric acid added. The beakers were covered with clean watch glasses and placed in a 199 
fume cupboard for 24h. The partially digested samples were placed on a hotplate and boiled for 1h 200 
before being transferred quantitatively to pre-cleaned 25 ml volumetric flasks and made to volume with 201 
2% v/v nitric acid. The digested samples were then analysed by ICO-OES using a Varian 725-ES 202 
instrument. Standards of between 0.5 and 120 mg/l Y were prepared as calibrants and the Y signal was 203 
monitored at two different wavelengths. Apparent digestibility coefficients (ADC) were estimated 204 
according to the formula: 205 
ADC = 100-100*((Yfeed/Yfaeces)*(Nfaeces/Nfeed)) 206 
where Yfeed = Yttrium oxide in feed, Yfaeces = Yttrium in faeces, Nfaeces = nutrient in faeces, Nfeed = 207 
nutrient in feed. All data were based on calculated dry weight of the samples. For fatty acid 208 
digestibilities, data were based on the amount of the individual component in µg mg-1 of total lipid.  209 
 210 
2.6. Lipid analyses  211 
 212 
 Liver and skinned and deboned flesh samples from the three fish per pen were prepared as pooled 213 
homogenates. Total lipid was extracted from diets or 1g portions of tissue homogenates by 214 
homogenising in 20 volumes of ice-cold chloroform/methanol (2:1, v/v) in an Ultra-Turrax tissue 215 
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disrupter (Fisher Scientific, Loughborough, U.K.). Total lipid was prepared according to the method of 216 
Folch et al. (1957) and non-lipid impurities removed by washing with 0.88% (w/v) KCl. The weight of 217 
lipid was determined gravimetrically after evaporation of solvent and overnight desiccation in vacuo.   218 
       Separation of lipid classes was performed by high-performance thin-layer chromatography 219 
(HPTLC).  Approximately 10 µg of total lipid was applied as 2 mm streaks and the plate developed to 220 
two-thirds distance with methyl acetate/isopropanol/chloroform/methanol/0.25 % aqueous KCl 221 
(25:25:25:10:9, by vol.).  After desiccation, the plate was fully developed with isohexane/diethyl 222 
ether/acetic acid (85:15:1, by vol.).  The lipid classes were quantified by charring at 160 oC for 15 min 223 
after spraying with 3 % (w/v) aqueous cupric acetate containing 8 % (v/v) phosphoric acid, followed by 224 
densitometry using a Shimadzu CS-9000 dual-wavelength flying spot scanner and DR-13 recorder 225 
(Henderson and Tocher, 1992). 226 
        Fatty acid methyl esters (FAME) from diets and tissue total lipid were prepared by acid-catalysed 227 
transesterification of total lipid according to the method of Christie (1993). Extraction and purification 228 
of FAME was performed as described by Tocher and Harvie (1988). FAME were separated and 229 
quantified by gas-liquid chromatography (Carlo Erba Vega 8160, Milan, Italy) using a 30m x 0.32 mm 230 
i.d. capillary column (CP Wax 52CB, Chrompak, London, U.K.) and on-column injection. Hydrogen 231 
was used as carrier gas and temperature programming was from 50oC to 150oC at 40oC min-1 and then 232 
to 230oC at 2.0oC min-1. Individual methyl esters were identified by comparison with known standards 233 
and by reference to published data (Ackman, 1980; Tocher and Harvie, 1988). Data were collected and 234 
processed using the Chromcard for Windows (version 1.19) computer package (Thermoquest Italia 235 
S.p.A., Milan, Italy). 236 
 237 
2.7. Gene expression 238 
 239 
RNA was extracted from liver samples by homogenising in 5ml of TriReagent using an Ultra-Turrax 240 
tissue disrupter (Fisher Scientific, Loughborough, U.K.). First strand cDNA synthesis of total RNA 241 
aliquots from pooled biological replicates was conducted using the Reverse-It Max reverse 242 
transcriptase kit (ABgene Ltd). Real-time qPCR was performed using a Quantica thermocycler 243 
(Techne). Reactions comprised a total volume of 15µl containing 5µl cDNA (10-2 dilution of 1st strand 244 
synthesis), 10 pmol each PCR primer and 7.5 µl 2 × Absolute QPCR SYBR Green Mix (ABgene Ltd). 245 
Primer sequences for the three target genes are given in Table 3. An initial incubation at 95°C for 15 246 
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min was employed in order to activate the Thermo-Start® DNA Polymerase. Forty-five cycles of PCR 247 
were performed. Each PCR cycle consisted of a denaturation step of 15 s at 95°C; annealing step of 15 248 
s at 60°C and an extension step of 30 s at 72°C. Following PCR melting curve analysis was performed 249 
to confirm the production of a single product in these reactions. Standard curves were established using 250 
five different dilutions (in triplicate) of cDNA sample solutions. Real-time efficiency was determined 251 
for each gene from the slopes given by Quantsoft software, applying the equation E = 10(-1/slope). The 252 
relative expression ratio of each gene was calculated using REST© software (http://www.gene-253 
quantification.info/). The relative expression ratio for a considered gene is based on the PCR efficiency 254 
(E) and CT of a sample compared with the control, and expressed in comparison to the reference genes 255 
(ie normalization with housekeepers), according to Pfaffl’s mathematical model (Pfaffl, 2001):  256 
Ratio = (Etarget)∆CT?target(control-sample)/(Ereference)∆CTreference(control-sample) 257 
for each gene by plotting CT values against the log10 of the serial dilutions. 258 
Statistical differences in gene expression between the control and samples were evaluated in group 259 
means by randomization tests (Pfaffl et al., 2002) using REST© software. Five thousand random 260 
allocations were performed and differences were considered to be significant at P < 0.05. 261 
 262 
2.7. Materials 263 
 264 
BHT and TriReagent were obtained from Sigma Chemical Co. (Poole, U.K.). HPTLC (10 cm x 10 cm 265 
x 0.15 mm) and TLC (20 cm x 20 cm x 0.25 mm) plates, precoated with silica gel 60 (without 266 
fluorescent indicator) were obtained from Merck (Darmstadt, Germany).  All solvents were HPLC 267 
grade and were obtained from Fisher Scientific UK, Loughborough, England. 268 
2.8. Statistical  analysis 269 
 270 
All data are presented as means ± SD (n value as stated).  The effects of dietary treatment were 271 
determined by one-way analysis of variance (ANOVA) followed, where appropriate, by Tukey’s 272 
comparison test (Zar, 1999). Percentage data and data which were identified as non-homogeneous 273 
(Bartlett’s test) were subjected to arcsine transformation before analysis.  Differences were regarded as 274 
significant when P < 0.05.  275 
 276 
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3. Results 277 
 278 
3.1 Fatty acid composition of the diets  279 
The fatty acid composition of the DFO diet showed some differences compared to the FO diet 280 
including lower levels of 18:1n-9 and 18:3n-3, but higher levels of 18:0, 20:1, 22:1, 18:2n-6 and EPA 281 
(Table 2).  However, most of these differences although significant were relatively minor. The SVO 282 
diets all showed increased 18:0, 18:2n-6 and 18:3n-3, and lower levels of 14:0, 16:0, ARA, EPA and 283 
DHA compared to the FO and DFO diets.  Within the SVO diets, 16:0, 18:0 and 18:2n-6 increased with 284 
increasing inclusion of soybean oil so that the rank order for their levels was SSO > SRO/SO > SRO, 285 
whereas 18:1n-9 and 18:3n-3 increased with increasing inclusion of rapeseed oil such that the rank 286 
order for their levels was SRO > SRO/SO > SS) (Table 2).  There was no significant difference 287 
between these diets in their levels of n-3HUFA. 288 
 289 
3.2. Growth performance, whole body composition and pigment content 290 
There were no significant differences in growth performance (final weights, SGR and TGC) among the 291 
dietary treatments (Table 4). There was also no dietary effect on feed efficiency (FCR). Other than 292 
slight differences in moisture, the different dietary oils had no effect on the gross composition of the 293 
whole salmon or the concentration of astaxanthin (Table 4).  294 
 295 
3.3. Apparent digestibility of gross nutrients and fatty acids 296 
The apparent digestibility of the DFO was significantly lower than all the other diets as evidenced by 297 
the lower values for crude protein, crude lipid and dry matter digestibility (Table 5). Consistent with 298 
this, the apparent digestibility of virtually every fatty acid was lower in fish fed the DFO diet compared 299 
to fish fed the FO diet (Table 5).  In addition, the digestibility of many fatty acids was often lower in 300 
fish fed the DFO diet compared to fish fed the SVO diets.  In general, fatty acid digestibility was 301 
highest in fish fed the FO diet.  There were few differences in fatty acid digestibilities between the fish 302 
fed the SVO diets. 303 
 304 
3.4. Flesh and liver lipid contents and class compositions 305 
 306 
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Liver lipid content was significantly lower in fish fed the SVO diets compared to fish fed either the FO 307 
or DFO diets (Table 6). There was a similar trend for flesh lipid content to be lower in fish fed the SVO 308 
diets compared to fish fed the FO or DFO diets, although this was only significant in the case of fish 309 
fed the SRO diet. There were no significant differences in tissue lipid contents between fish fed the FO 310 
and DFO diets. Consistent with this, there were no significant effects on flesh or liver lipid class 311 
composition between fish fed the FO and DFO diets other than slightly higher cholesterol in liver of 312 
fish fed DFO (Table 7).  In contrast, the proportions of neutral lipids were reduced and polar lipids 313 
increased in both flesh and liver of salmon fed the SVO diets compared to fish fed the FO or DFO diets 314 
(Table 7).  The lower neutral lipid was primarily due to decreased proportions of triacylglycerol (TAG) 315 
in both tissues and also steryl esters in liver. The greater proportions of polar lipids in fish fed the SVO 316 
diets were mainly due to increased proportions of the two main phosphoglycerides, 317 
phosphatidylcholine and phosphatidylethanolamine, in both flesh and liver. One of the few differences 318 
between the fish fed the SVO diets was that the flesh of fish fed the diet with highest level of soybean 319 
oil (SSO) had a lower proportion of TAG and a higher proportion of cholesterol (sterol) than fish fed 320 
the other SVO diets.  The proportion of free fatty acids in the flesh also increased with increasing 321 
inclusion of dietary soybean oil. 322 
 323 
3.5. Flesh and liver fatty acid compositions 324 
 325 
Flesh fatty acid compositions were largely changed corresponding to the fatty acid compositions of the 326 
diets with fish fed the SVO diets having reduced 14:0, 16:0, EPA, DHA and arachidonic acid (ARA), 327 
but increased 18:2n-6 and 18:3n-3 compared to fish fed the FO and DFO diets (Table 8). The 328 
proportions of 18:0 and 18:1n-9 were only increased in fish fed the diets containing soybean oil and 329 
rapeseed oil, respectively. Therefore, as with the diets, flesh 16:0, 18:0 and 18:2n-6 increased with 330 
increasing inclusion of soybean oil so that the rank order for their proportions was SSO > SRO/SO > 331 
SRO, whereas flesh 18:1n-9 and 18:3n-3 increased with increasing inclusion of rapeseed oil such that 332 
the rank order for their proportions was SRO > SRO/SO > SSO.  Interestingly, the proportions of EPA 333 
and DHA were significantly higher in fish fed the diet with highest level of soybean oil (SSO) 334 
compared to the other SVO diets.  Reflecting the diet, EPA and total n-3PUFA were higher in fish fed 335 
DFO than FO, whereas 18:1n-9 was lower (Table 8).  In contrast, there were no significant differences 336 
in fatty acid composition of liver between fish fed the FO and DFO diets (Table 9).  The proportions of 337 
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18:0, 18:1n-9, 18:2n-6 and 18:3n-3 in liver of fish fed the SVO diets were similar to those described 338 
above for flesh, and reflected the dietary fatty acid compositions.  However, it was noteworthy that 339 
increased proportions of desaturated and elongated products of 18:2n-6 and 18:3n-3 were clearly 340 
observed in liver of fish fed the SVO diets.  Thus, proportions of 20:2n-6, 20;3n-6 and 20:4n-6 were all 341 
increased in fish fed the SVO diets compared to fish fed the FO and DFO diets.  Even more striking 342 
was the increased proportions of EPA in the livers of fish fed the SVO diets. In contrast, proportions of 343 
22:5n-3 and, to a lesser extent, DHA were reduced in fish fed the SVO diets compared to fish fed FO or 344 
DFO (Table 9). 345 
  346 
3.6. Gene expression 347 
 348 
      The expression of both the Δ6- and Δ5-fatty acyl desaturase genes in liver was increased in fish fed 349 
the SVO diets, with the highest expression observed in liver of fish fed the highest inclusion of soybean 350 
oil (diet SSO) (Fig.1). In contrast, there was no dietary effect on the hepatic expression of the PUFA 351 
elongase gene.  There were also no significant differences in expression of any of the genes between 352 
fish fed the FO and DFO diets.  353 
 354 
4. Discussion 355 
 356 
There were no deleterious effects on growth as measured by final weights, SGR or TGC, or on feed 357 
efficiency (FCR) of any of the SVO diets.  This was consistent with the results of several previous 358 
trials in which partial replacement of fish oil by VO, or even 100% replacement, have had no 359 
significant effects on growth performance or feed efficiency in Atlantic salmon when using fish meal-360 
based diets (see Bell and Waagbø, 2008). It was also consistent with the analytical data on the 361 
digestibilities of gross nutrients and individual fatty acids that were all very similar to those of the FO 362 
diet.  In contrast, the apparent digestibility of the DFO diet was significantly lower than that of all the 363 
other diets, including the FO diet. There were some significant differences in fatty acid composition 364 
between the DFO and FO diets, and so some differences in fatty acid and, consequently lipid, 365 
digestibility may not be entirely unexpected.  However, the lower digestibilities of the DFO diet also 366 
included the crude protein and dry matter and so it appeared to be a general effect.  It is not known if 367 
the decontamination process per se was responsible for these effects, but the fish oil and 368 
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decontaminated fish oil used in the diet manufacture were exactly the same oil, simply decontaminated 369 
or not.  Therefore, it is probable that the decontamination process affected the digestibility, but we 370 
cannot be certain without further evidence.  Furthermore, it was surprising that the lower digestibilities 371 
of the DFO diet did not result in lower growth, as the fish fed the DFO diet attained the same final 372 
weight and showed the same SGR and TGC as fish fed the FO diet, and the SVO diets.  Feed 373 
efficiencies were also unaffected and so the lower digestibilities with the DFO diet were not reflected 374 
in any gross growth performance parameter. This apparent dichotomy between nutrient digestibilities, 375 
and growth and feed efficiency has been observed before in dietary trials in salmon (Torstensen et al., 376 
2000). Thermal growth coefficient (TGR) was higher and FCR lower in Atlantic salmon held in 377 
seawater compared to those in freshwater, despite lower ADC values for dry matter and crude protein 378 
(Krogdahl et al., 2004). In comparison to the FO diet, the SVO diets also showed lower lipid 379 
digestibility related to lower digestibilities of a number of fatty acids, but crude protein digestibility 380 
was not affected by feeding VOs. Lipid and fatty acid digestibility in salmon fed VOs appears to be 381 
variable (Torstensen et al., 2000; Bendiksen et al., 2003; Ng et al., 2004), but lower lipid/FA 382 
digestibility of diets formulated with VO has been reported previously in trials with salmon (Menoyo et 383 
al., 2003) and other fish species including Murray cod (Francis et al., 2007). As with the DFO diet, the 384 
lower lipid digestibility did not result in any deleterious effect on growth performance or feed 385 
efficiency.   386 
       The composition of the fish was unaffected by feeding the DFO diet compared to the FO diet, with 387 
whole body proximate compositions, liver and flesh lipid contents and lipid class compositions all 388 
being unaffected. Although the SVO diets also had no effect on the gross composition of the fish, their 389 
effect in lowering liver lipid was highly significant. Although, not statistically significant, it appeared 390 
that the liver lipid lowering effect was greater with the diets containing soybean compared to rapeseed 391 
oil. Differences between VOs in their effects on tissue lipid contents have been observed previously. 392 
Thus earlier trials on salmon smolts showed that substitution of FO with graded levels of palm oil had 393 
no significant effect on liver lipid (Bell et al., 2002), whereas graded substitution with rapeseed oil 394 
tended to increase liver lipid (significantly so at 100% replacement) (Bell et al., 2001). Liver lipid was 395 
not increased in salmon fed soybean oil at higher water temperatures (Ruyter et al., 2006). 396 
Furthermore, liver lipid content was lower in salmon fed a VO blend containing rapeseed, palm and 397 
linseed oils, for 16 months but not at 14 and 22 months of feeding (Jordal et al., 2007). In that study, 398 
the relative proportions of TAG and cholesterol were increased and decreased, respectively, at all 399 
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stages. Thus, the effects of VO diets on liver lipid levels can vary perhaps related to type of oil, water 400 
temperature, season and duration of trial. In the present study, the lower liver lipid level in fish fed the 401 
SVO diets was associated with decreased neutral lipids, especially TAG and steryl esters whereas the 402 
major membrane lipids, phosphatidylcholine, phosphatidylethanolamine and, possibly, 403 
cholesterol/sterol were all increased. In Table 7 we have reported sterols rather than cholesterol as the 404 
TLC method is not able to separate cholesterol from many plant sterols. The VO diets are likely to 405 
contain lower levels of cholesterol but, conversely, may contain a range of other plant sterols (Padley et 406 
al., 1986).  Plant sterols are generally not absorbed by animals and, indeed, are used to block 407 
cholesterol uptake in humans.  The situation with fish is not known but it is likely similar.  Therefore, it 408 
is likely that cholesterol is the predominant sterol in fish tissues, but the presence of plant sterols cannot 409 
be excluded completely.  However, the higher cholesterol level in liver (and flesh) of fish fed the SVO 410 
diets may be a compensatory mechanism, the result of increased cholesterol synthesis in response to 411 
reduced dietary cholesterol (Taggart et al., 2008).  412 
      Possibly more important in terms of product quality, is the effect that different VOs have on flesh 413 
lipid contents in salmon. In the present trial, although there was a trend for flesh lipid content to be 414 
lower in fish fed the SVO diets, it was only significantly reduced in fish fed the SRO diet, that is, with 415 
60% rapeseed oil substitution. Previously, graded rapeseed oil substitution in salmon smolts tended to 416 
decrease flesh lipid, although this effect was only significant at the 50% replacement level. (Bell et al., 417 
2001). With palm oil substitution in salmon smolts, the flesh lipid lowering effect was very 418 
pronounced, with lipid levels decreasing in a graded manner as the level of palm oil substitution 419 
increased (Bell et al., 2002). In a study with larger post-smolts, feeding palm oil reduced flesh lipid 420 
content compared to fish fed fish, sunflower or a blend of fish and sunflower oil (Torstensen et al., 421 
2000). In a trial feeding salmon a VO blend containing rapeseed, palm and linseed oils over the entire 422 
2-year growth cycle, flesh lipid contents were generally lower at all points in both the freshwater and 423 
seawater phases (Torstensen et al., 2005). In that trial, neutral lipid and TAG were reduced in white 424 
muscle of salmon fed the VO blend compared to fish fed FO (Nanton et al., 2007). Similarly, in the 425 
present trial, the lipid class composition of the flesh in fish fed the SVO diets was characterized by 426 
decreased proportions of neutral lipid and TAG. Overall, it is apparent that the effect that substitution 427 
of FO with VO has on tissue lipid contents and compositions is dependent upon a number of factors 428 
including the specific VO or VO blends used as well as other factors including the specific tissue itself 429 
and possibly growth stage and/or season as well as the genetic origin of the stock. 430 
 16 
           The small, but significant, differences in the fatty acid compositions of the FO and DFO diets 431 
cannot be directly attributed to the decontamination process but it is possible. For instance, certain fatty 432 
acids could be slightly more adsorbed by the activated carbon than other fatty acids resulting in lower 433 
proportions in DFO compared to FO.  However, the differences observed, lower levels of 18:1n-9 and 434 
18:3n-3, and higher levels of 18:0, 20:1, 22:1, 18:2n-6 and EPA in DFO compared to FO, did not 435 
follow a pattern that could be easily explained by differential adsorption. Some of these differences, 436 
particularly the lower level of 18:1n-9 and higher levels of 20:1, 22:1 and EPA were reflected in flesh 437 
lipids but not liver lipids, that showed identical compositions in fish fed the FO and DFO diets. The 438 
fact that flesh was more affected than liver by differences in dietary fatty acid composition is 439 
predictable based on the lipid content of flesh compared to liver in salmon. The higher lipid content is 440 
associated with higher neutral (storage) lipid, specifically TAG, that is more readily influenced by diet 441 
than phospholipid (Bell and Waagbø, 2008).  This simple fact is why changes in dietary lipid have such 442 
an impact on salmon flesh composition and why it is, as a consequence, difficult to minimize these 443 
effects. This was clearly demonstrated in the present trial where the strategy with VO substitution was 444 
to blend them with southern hemisphere fish oil in an attempt to minimize the impact of the VO 445 
inclusion on n-3HUFA was, unfortunately only partially successful with flesh. Thus, despite 60% of 446 
the FO being replaced by VOs, the EPA levels in the salmon flesh were only slightly reduced from 447 
about 6% to 5%. However, DHA was reduced more severely from around 13% to about 6.5 to 7.5%.  448 
This simply reflected the diets that also showed quite significantly reduced DHA but relatively less 449 
effect on EPA, which was expected as, although southern hemisphere fish oils have higher n-3HUFA 450 
than northern hemisphere fish oils, this is due to high percentages of EPA and a high EPA:DHA ratio, 451 
but reduced or similar DHA compared to northern FO.  452 
     In contrast, the strategy was largely successful in liver as fatty acid compositions of fish fed the 453 
SVO diets showed impressive levels of HUFA with ARA and EPA both being significantly increased, 454 
and DHA only reduced from around 21% to about 18-19%.  EPA actually increased from 7.7% in fish 455 
fed the FO and DFO diets to 9-10% in fish fed the SVO diets. The only negative impact being 456 
increased 18:2n-6 and reduced 18:1n-9 in the diets containing soybean oil. It is important to emphasize 457 
that the increased EPA and ARA were not simply the result of increased deposition and retention, but 458 
were also the result of conversion of dietary 18:3n-3 and 18:2n-6, respectively.  This contention is 459 
supported by other evidence.  The SVO diets, although formulated with 40% southern hemisphere fish 460 
oil, which is known to be richer in EPA than northern hemisphere fish oils (Sargent et al., 1989), were 461 
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still lower in EPA than the FO and DFO diets. Similarly, the ARA levels in the SVO diets were lower 462 
than in the FO and DFO diets.  Further evidence of active desaturation was provided by the increased 463 
level of the intermediate 20:3n-6 in the liver of fish fed the diets containing soybean, although there 464 
was also increased production of the dead-end fatty acid 20:2n-6, the direct elongation product of 465 
18:2n-6. Increased proportions of 20:2n-6 and 20:3n-6 have been observed previously in salmon when 466 
fed diets containing high levels of 18:2n-6  (Bell et al., 1991, 2001, 2002, 2003b; Lie et al., 1993; 467 
Tocher et al., 2003). Thus, the increased proportions of EPA and ARA in liver were the result of 468 
enhanced desaturation and elongation of dietary 18:3n-3 and 18:2n-6.  The increased hepatic 469 
expression of fatty acyl desaturase genes observed in the present trial is entirely consistent with this 470 
assertion. We have previously demonstrated that increased expression of fatty acyl genes in liver of 471 
salmon fed VOs was associated with increased activity of the HUFA biosynthesis pathway (Zheng et 472 
al., 2004, 2005a). 473 
        The increased percentages of EPA observed in fish fed the SVO diets was especially noteworthy 474 
as it is unusual that dietary VO did not reduce EPA levels, let alone increase them. As mentioned 475 
above, it is common to observe increased levels of desaturation products of dietary 18:2n-6 including, 476 
most commonly, 20:3n-6, in trials with salmon fed VO (Bell et al., 1991, 2001, 2002, 2003b; Lie et al., 477 
1993; Tocher et al., 2003).  Bell et al. (1991) also found increased levels of ARA in phospholipids from 478 
liver, heart and retina in salmon fed sunflower oil. Increased ARA was also observed in total lipid from 479 
liver of salmon fed a rapeseed/palm/linseed blend (Zheng et al., 2005a). As essentially all VO diets will 480 
increase dietary 18:2n-6 in comparison to FO diets, this has been a widely reported observation in 481 
salmon tissues, especially liver. However, a similar phenomenon has not been generally observed with 482 
18:3n-3. Therefore, increasing dietary 18:3n-3 levels have not been able to maintain tissue EPA or 483 
DHA at levels obtained in salmon fed FO.  Indeed, even increased levels of 18:4n-3 or 20:4n-3, 484 
intermediates in the pathway from 18:3n-3 to EPA, have been only rarely been reported.  In a trial 485 
using graded substitution of FO with linseed oil, 18:4n-3 and 20:4n-3 were increased in salmon liver 486 
lipids in a graded manner (Tocher et al., 2002).  However, EPA, 22:5n-3 and DHA all decreased as the 487 
level of linseed oil substitution increased. Direct biochemical measurements of fatty acyl desaturation 488 
activities in hepatocytes and enterocytes have conclusively confirmed that HUFA synthesis is up-489 
regulated in salmon fed diets containing VOs, including rapeseed (Bell et al., 2001), palm (Bell et al., 490 
2002) and linseed oils (Tocher et al., 2002).  Molecular studies demonstrated that the mechanism 491 
includes increased desaturase gene expression (Zheng at al., 2004, 2005a: Jordal et al., 2005). Thus, in 492 
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previous trials when dietary FOs were substituted by VOs, the reductions in the levels of dietary EPA 493 
and DHA have been too great for the conversion of dietary 18:3n-3 by the HUFA synthesis pathway to 494 
maintain the tissue levels of EPA or DHA.  The precise reason for this observation remains 495 
unexplained but it was very interesting that EPA levels in salmon fed the SVO diets were higher than 496 
the levels of EPA in fish fed the FO and DFO diets in the present trial.  497 
     Another interesting factor in the observation above is that there was a difference between rapeseed 498 
and soybean oil substitution, with the latter, especially the SSO diet with sole replacement by soybean 499 
oil, showing the greatest effect.  Thus, the percentages of DHA and EPA in both liver and flesh were 500 
higher in fish fed the SSO diet compared to fish fed the SRO diet with rapeseed oil substitution. The 501 
difference between fish fed SSO and SRO was highly significant in flesh with total n-3HUFA levels of 502 
15.3 versus 13.4%, respectively, with reciprocal differences in substrate 18:3n-3 levels of 3.2 versus 503 
5.6%. Consistent with this, the induction of fatty acyl desaturase expression in liver was greatest in the 504 
fish fed the SSO diet.  It is not clear why this should be.  Previous trials on salmonids using substitution 505 
of FO with soybean oil have not shown such an effect (Hardy et al., 1987; Guillou et al., 1995; Ruyter 506 
et al., 2006). The current paradigm is that it is low dietary HUFA that induces increased desaturase 507 
expression (Tocher, 2003), but there was very little difference between the SRO and SSO diets in terms 508 
of HUFA content. In contrast, the SSO diet was characterized by very high levels of 18:2n-6 and lower 509 
18:3n-3 than the SRO diet. In a study comparing different proportions of 18:1n-9, 18:2n-6 and 18:3n-3 510 
(supplied by olive, sunflower and linseed oils, respectively) in diets for Atlantic salmon parr, the 511 
authors suggested that the desaturation and elongation of 18:2n-6 and 18:3n-3 may be stimulated by 512 
substrate availability as they noted the extent of conversion differed despite dietary HUFA levels all 513 
being identical (Rollin et al., 2003). Although it is known that, like most vertebrate desaturases, the 514 
salmon desaturases are more active towards n-3 than n-6 substrates (Hastings et al., 2004; Zheng et al., 515 
2005b), how this particular combination of 18:2n-6 and 18:3n-3 could have such a significant effect is 516 
unclear.  Certainly, previous trials that used VOs blends to produce a better balance of 18:2n-6 and 517 
18:3n-3 including rapeseed/linseed oils (Bell et al., 2003b; Tocher et al., 2003) or 518 
rapeseed/palm/linseed oils (Zheng et al., 2005a) have not been effective in maintaining EPA. However, 519 
these trials were of longer duration and there may have been a transient increase in HUFA, following 520 
change of diet, that was not observed due to the frequency of sampling used. 521 
        In conclusion, we tested the hypotheses that blending VOs with southern hemisphere fish oil is a 522 
strategy that may result in lower impact upon tissue n-3HUFA levels, and that the decontamination of 523 
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fish oil will have no major effect on the nutritional quality of fish oil as a feed ingredient for Atlantic 524 
salmon. Neither the SVO diets nor the DFO diet had any deleterious effects on growth as measured by 525 
final weights, SGR or TGC, or on feed efficiency (FCR). Therefore, despite lower apparent 526 
digestibility, decontamination of fish oil did not significantly impact on its nutritional quality for 527 
salmon. The partial replacement of fish oil with blends of VOs and southern hemisphere fish oil had 528 
minimal impact on HUFA levels in liver, but a greater effect on flesh HUFA levels.  Soybean oil had 529 
significantly less impact than rapeseed oil. Decontamination of fish oil had no effect on the n-3HUFA 530 
content of flesh of salmon fed the oil. 531 
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 710 
Fig.1. Effects of diet on the hepatic expression of fatty acyl Δ6 (Delta-6) and Δ5 (Delta-5) desaturases, 711 
and polyunsaturated fatty acid elongase (Elongase) in Atlantic salmon. Results were calculated by 712 
REST 2005 software with β-actin as reference (normalization) gene and expressed relative to 713 
expression in fish fed the fish oil diet (FO). Asterisks indicate that the expression of the specific gene in 714 
fish fed a particular diet was significantly difference (P < 0.05) to its expression in fish fed the FO diet. 715 
DFO, decontaminated northern fish oil; FO, northern fish oil; SRO, southern fish oil and rapeseed oil; 716 
SRO/SO, southern fish oil, rapeseed oil and soybean oil; SSO, southern fish oil and soybean oil. 717 
718 
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Table 1. Formulations, proximate compositions (g kg
-1
), energy (kJ g
-1
) and pigment contents 
(mg kg
-1
) of experimental diets fed to Atlantic salmon for 10 weeks  
 
Diets  
FO DFO SRO SRO/SO SSO 
Fish meals 378 378 378 378 378 
Legume/oilseed 
meals 
149 149 149 149 149 
Northern fish oil 325 - - - - 
Northern fish oil 
(decontaminated) 
- 325 - - - 
Southern fish oil - - 130 130 130 
Rapeseed oil - - 195 98 - 
Soybean oil - - - 98 195 
Binder 140 140 140 140 140 
Premixes 9.2 9.2 9.2 9.2 9.2 
Composition      
Crude protein 326 ± 1.0
a
 322 ± 1.1
 b
 314 ± 2.0
 c
 328 ± 1.0
 a
 326 ± 1.0
 a
 
Crude lipid 336 ± 1.0
 c
 343 ± 2.2
 ab
 345 ± 3.9
 ab
 342 ±1.0
 b
 347 ± 1.0 
a
 
Moisture 60 ± 1.0
 a
 55 ± 1.0 
b
 63 ± 1.1
 a
 55 ± 0.3
 b
 52 ± 1.0
 c
 
Fiber 21 ± 2.0
 
 22 ± 1.9 19 ± 1.4 20 ± 1.0 20 ± 2.1
 
 
Ash 78 ± 1.0
 ab
 77 ± 1.0
 b
 76 ± 1.1
 c
 78 ± 0.2
 ab
 78 ± 1.0
 a
 
      
Digestible energy  25.3 ± 0.3 25.3 ± 0.1 25.2 ± 0. 1  25.2 ± 0. 1  25.3 ± 0. 2  
Astaxanthin  22.6 ± 0.1
a
 18.1 ± 1.1
b
 15.2 ± 0.1
c
 20.1 ± 1.9
b
 18.5 ± 0.3
b
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. DFO, decontaminated northern 
fish oil; FO, northern fish oil; SRO, southern fish oil and rapeseed oil; SRO/SO, 
southern fish oil, rapeseed oil and soybean oil; SSO, southern fish oil and soybean oil.  
 
 28 
719 
 29 
 719 
720 
Table 2. Fatty acid compositions (percentage of total fatty acids) of the experimental 
diets 
  
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Includes 15:0 and 20:0 at up to 
0.7%; 
2
Includes 16:1n-9, 20:1n-11, 20:1n-7 and 22:1n-9 at up to 0.5%; 
3
Includes 
18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 at up to 0.6%; 
4
Includes 20:3n-3 and 
20:4n-3 at up to 0.5%. DFO, decontaminated northern fish oil; FO, northern fish oil; 
PUFA, polyunsaturated fatty acids; SRO, southern fish oil and rapeseed oil; SRO/SO, 
southern fish oil, rapeseed oil and soybean oil; SSO, southern fish oil and soybean oil. 
 FO DFO SRO SRO/SO SSO 
14:0 5.2 ± 0.1
b
 5.6 ± 0.3
a
 2.9 ± 0.0
c
 2.9 ± 0.1
c
 2.9 ± 0.2
c
 
16:0 19.2 ± 0.4
a
 18.8 ± 0.7
a
 10.9 ± 0.0
d
 13.5 ± 0.2
c
 15.0 ± 0.7
b
 
18:0 2.2 ± 0.0
e
 3.3 ± 0.1
d
 3.8 ± 0.1
c
 4.4 ± 0.1
b
 4.8 ± 0.2
a
 
22:0 0.3 ± 0.1
b
 0.6 ± 0.7
ab
 1.5 ± 0.5
a
 1.4 ± 0.2
 ab
 1.4 ± 0.3
ab
 
Total saturated
1
 27.8 ± 0.6
a
 29.3 ± 0.5
a
 20.0 ± 0.5
c
 23.1 ± 0.5
b
 24.9 ± 1.5
b
 
16:1n-7 6.0 ± 0.1
a
 5.8 ± 0.1
b
 2.7 ± 0.0
c
 2.7 ± 0.0
c
 2.6 ± 0.1
c
 
18:1n-9 25.9 ± 0.1
c
 21.6 ± 0.7
d
 41.2 ± 0.5
a
 29.5 ± 0.1
b
 21.2 ± 2.0
d
 
18:1n-7 2.5 ± 0.1
b
 2.5 ± 0.1
b
 2.9 ± 0.1
a
 2.6 ± 0.0
b
 2.2 ± 0.0
c
 
20:1n-9 2.1 ± 0.0
b
 3.2 ± 0.2
a
 1.2 ± 0.0
c
 0.9 ± 0.0
d
 0.6 ± 0.0
e
 
22:1n-11 2.4 ± 0.0
b
 4.1 ± 0.1
a
 0.3 ± 0.0
d
 0.3 ± 0.0
d
 0.4 ± 0.0
c
 
24:1n-9 2.0 ± 0.2
a
 1.6 ± 0.0
a
 0.3 ± 0.1
b
 0.3 ± 0.0
b
 0.2 ± 0.0
b
 
Total monoenes
2
 42.0 ± 0.1
b
 40.0 ± 0.8
b
 48.9 ± 0.7
a
 36.5 ± 0.1
c
 27.5 ± 1.8
d
 
18:2n-6 3.8 ± 0.1e 4.3 ± 0.0d 12.6 ± 0.1c 23.1 ± 0.1b 32.0 ± 0.4a 
20:4n-6 0.6 ± 0.0
a
 0.6 ± 0.0
a
 0.4 ± 0.0
b
 0.4 ± 0.0
b
 0.4 ± 0.0
b
 
Total n-6 PUFA
3
 5.6 ± 0.2
e
 5.9 ± 0.0
d
 13.4 ± 0.1
c
 23.9 ± 0.2
b
 32.7 ± 0.5
a
 
18:3n-3 2.7 ± 0.0
d
 2.3 ± 0.1
e
 6.3 ± 0.1
a
 5.1 ± 0.1
b
 3.7 ± 0.2
c
 
18:4n-3 2.2 ± 0.0
a
 2.3 ± 0.1
a
 0.9 ± 0.0
b
 0.9 ± 0.0
b
 0.9 ± 0.0
b
 
20:5n-3 6.7 ± 0.1
b
 7.2 ± 0.3
a
 5.4 ± 0.1
c
 5.2 ± 0.1
c
 5.1 ± 0.1
c
 
22:5n-3 0.7 ± 0.0 0.7 ± 0.0 0.4 ± 0.4 0.6 ± 0.0 0.6 ± 0.0 
22:6n-3 11.6 ± 0.2
a
 11.4 ± 0.8
a
 4.3 ± 0.0
b
 4.3 ± 0.1
b
 4.2 ± 0.0
b
 
Total n-3 PUFA
4
 24.7 ± 0.4
a
 24.7 ± 1.3
a
 17.7 ± 0.2
b
 16.5 ± 0.4
bc
 14.9 ± 0.1
c
 
Total PUFA 30.3 ± 0.5
c
 30.6 ± 1.3
c
 31.1 ± 0.2
c
 40.4 ± 0.6
b
 47.7 ± 0.4
a
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Table 3. Primer sequences for target and housekeeping (normalisation) genes used in 
 real-time qPCR    
        
Gene Primer Sequence 5' - 3' Size (bp) 
5 Desaturase F GTGAATGGGGATCCATAGCA 1 9 2  
 R AAACGAACGGACAACCAGA  
6 Desaturase F CCCCAGACGTTTGTGTCAG  1 8 1  
 R CCTGGATTGTTGCTTTGGAT   
Elongase F TGATTTGTGTTCCAAATGGC  2 1 9  
 R CTCATGACGGGAACCTCAAT   
Elongation factor-1  F CTGCCCCTCCAGGACGTTTACAA  
(Housekeeping) R CACCGGGCATAGCCGATTCC  
-Actin F ACATCAAGGAGAAGCTGTGC 141 
(Housekeeping) R GACAACGGAACCTCTCGTTA   
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Table 4. Growth performance, proximate composition of whole fish (g kg
-1
) and pigment 
content (mg kg
-1
) of Atlantic salmon fed the experimental diets for 10 weeks 
 
 FO DFO SRO SRO/SO SSO 
Growth       
Initial weight (kg) 0.77 ± 0.02 0.78 ± 0.03 0.78 ± 0.03 0.77 ± 0.01 0.79 ± 0.11 
Final weight (kg) 2.19 ± 0.05 2.18 ± 0.07 2.18 ± 0.10 2.19 ± 0.05 2.20 ± 0.07 
SGR 1.35 ± 0.05 1.34 ± 0.01 1.34 ± 0.01 1.35 ± 0.03 1.33 ± 0.03 
TGC 3.92 ± 0.15 3.86 ± 0.04 3.87 ± 0.07 3.89 ± 0.10 3.87 ± 0.10 
FCR 0.98 ± 0.00 0.98 ± 0.02 0.98 ± 0.00 0.96 ± 0.02 0.96 ± 0.01 
Composition       
Protein 169 ± 3 167 ± 4 167 ± 5 170 ± 7 170 ± 4 
Lipid 191 ±10 189 ± 18 188 ± 14 194 ± 20 178 ± 27 
Ash 2.8 ± 0.3 3.1 ± 0.2 2.8 ± 0.5 3.1 ± 0.5 2.9 ± 0.4 
Moisture 616 ± 11
 a
 611 ± 12
ab
 614 ± 8
ab
 601 ± 5
b
 606 ± 13
ab
 
Astaxanthin 4.7 ± 0.3 4.3 ± 0.3 4.8 ± 0.4 4.8 ± 0.6 4.4 ± 0.6 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. DFO, decontaminated northern 
fish oil; FCR, feed conversion ratio; FO, northern fish oil; SGR, specific growth rate; 
SRO, southern fish oil and rapeseed oil; SRO/SO, southern fish oil, rapeseed oil and 
soybean oil; SSO, southern fish oil and soybean oil; TGC, thermal growth coefficient.  
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Table 5. Apparent digestibility coefficients (ADC) of gross nutrients and fatty acids in 
salmon fed the experimental diets 
 
Parameters FO DFO SRO SRO/SO SSO 
Protein 83.2 ± 1.3
ab
 79.5 ± 0.2
c
 83.4 ± 0.4
a
 84.2 ± 0.6
a
 81.5 ± 1.5
b
 
Lipid  95.0 ± 0.6
a
 91.2 ± 0.4
d
 94.1 ± 0.1
b
 93.6 ± 0.1b
c
 92.8 ± 0.8
c
 
Dry matter 69.3 ± 1.9
ab
 62.3 ± 0.5
c
 70.4 ± 0.8
a
 70.8 ± 1.4
a
 67.0 ± 2.7
b
 
      
Fatty acid      
14:0 98.0 ± 0.3a 94.5 ± 1.1b 94.5 ± 0.1b 94.6 ± 1.0b 94.9 ± 1.2b 
16:0 97.2 ± 0.2a 92.4 ± 1.2c 93.9 ± 0.2b 94.7 ± 1.2b 96.2 ± 0.5a 
18:0 86.2 ± 1.2b 73.3 ± 4.5c 93.2 ± 0.6a 94.3 ± 1.4a 94.6 ± 2.2a 
Total saturated 95.7 ± 0.3a 89.0 ± 1.7c 94.0 ± 0.4b 94.7 ± 1.2ab 95.6 ± 0.8ab 
16:1n-7 98.8 ± 0.2a 97.5 ± 0.6b 97.4 ± 0.1b 97.6 ± 0.3b 97.7 ± 0.3b 
18:1n-9 99.0 ± 0.1a 97.9 ± 0.5c 98.4 ± 0.2b 98.2 ± 0.3bc 98.3 ± 0.3bc 
18:1n-7 98.4 ± 0.3a 96.6 ± 0.6c 97.4 ± 0.2b 97.4 ± 0.4b 97.5 ± 0.4b 
20:1n-9 98.5 ± 0.1a 96.6 ± 0.5c 97.4 ± 0.3b 96.7 ± 0.6c 97.0 ± 0.3bc 
22:1n11 97.1 ± 3.0 97.2 ± 1.6 96.5 ± 0.3 95.8 ± 1.0 96.6 ± 0.4 
Total monoenes 98.7 ± 0.1a 97.3 ± 0.6c 98.2 ± 0.2ab 98.0 ± 0.3b 98.0 ± 0.3b 
18:2n-6 99.8 ± 0.1b 99.8 ± 0.1a 99.8 ± 0.1a 99.8 ± 0.1a 99.8 ± 0.1a 
20:4n-6 98.8 ± 0.1 97.4 ± 0.5 99.2 ± 1.5 98.3 ± 1.9 99.2 ± 1.5 
Total n-6 PUFA 98.8 ± 0.1b 97.6 ± 0.5c 98.8 ± 0.1b 99.1 ± 0.3ab 99.3 ± 0.2a 
18:3n-3 99.3 ± 0.1a 98.4 ± 0.4c 98.8 ± 0.2b 98.7 ± 0.2bc 98.6 ± 0.3bc 
18:4n-3 99.3 ± 0.1a 98.6 ± 0.4b 98.7 ± 0.6b 99.0 ± 0.1ab 98.8 ± 0.2b 
20:5n-3 99.2 ± 0.1a 98.2 ± 0.4c 98.7 ± 0.1b 98.7 ± 0.1b 98.5 ± 0.3bc 
22:5n-3 98.9 ± 0.1a 97.5 ± 0.5a 96.0 ± 1.8b 97.8 ± 0.2a 97.8 ± 0.3a 
22:6n-3 98.8 ± 0.1a 97.2 ± 0.5b 96.9 ± 0.4b 96.8 ± 0.5b 96.7 ± 0.4b 
Total n-3 PUFA 99.0 ± 0.1a 97.8 ± 0.4c 98.3 ± 0.2b 98.2 ± 0.2b 98.0 ± 0.3b 
Total PUFA 99.0 ± 0.1a 97.8 ± 0.4c 98.4 ± 0.2b 98.4 ± 0.2b 98.4 ± 0.3b 
 
Results are means ± SD (n = 4). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. DFO, decontaminated northern 
fish oil; FO, northern fish oil; PUFA, polyunsaturated fatty acids. SRO, southern fish 
oil and rapeseed oil; SRO/SO, southern fish oil and rapeseed and soybean oils; SSO, 
southern fish oil and soybean oil.  
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Table 6. Lipid contents (percentage of wet weight) of flesh and liver of salmon at the 
end of the dietary trial 
 
Diet Flesh Liver 
FO 11.3 ± 1.3
a
 8.0 ± 2.8
a
 
DFO 11.2 ± 1.3
a
 7.0 ± 2.0
a
 
SRO 9.8 ± 0.8
b
 5.0 ± 1.0
b
 
SRO/SO 10.9 ± 1.1
ab
 4.7 ± 0.8
b
 
SSO 10.6 ± 1.2
ab
 4.4 ± 0.7
b
 
 
Results are means ± SD (n = 3 ). Values within a column with different superscript 
letters are significantly different as determined by ANOVA. DFO, decontaminated 
northern fish oil; FO, northern fish oil; PUFA, polyunsaturated fatty acids. SRO, 
southern fish oil and rapeseed oil; SRO/SO, southern fish oil and rapeseed and 
soybean oils; SSO, southern fish oil and soybean oil.  
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Table 7. Lipid class composition (percentage of total lipid) of salmon flesh and liver 
at the end of the feeding trial.  
 
Lipid class F O  D F O  S R O  SRO/SO  S S O  
Flesh      
P C  4.6 ± 0.4
b
 5.0 ± 0.6
b
 6.5 ± 0.7
a
 5.6 ± 0.6
a
 5.4 ± 0.6
a
 
P E  3.1 ± 0.4
b
 3.3 ± 0.4
b
 4.1 ± 0.5
a
 4.2 ± 0.6
a
 4.4 ± 0.6
a
 
P S  n .d .  n .d .  n .d .  n .d .  n .d .  
P I  n .d .  n .d .  n .d .  n .d .  n .d .  
S M  n .d .  n .d .  n .d .  n .d .  n .d .  
      
Total PL  7.7 ± 0.7
 b
 8.3 ± 1.0
b
 10.6 ± 1.1
a
 9.8 ± 1.2
a
 9.7 ± 1.1
a
 
Total NL 92.2 ± 0.5
a
 91.7 ± 1.0
ab
 89.5 ± 1.3
d
 90.9 ± 1.9
bc
 90.3 ± 1.0
 cd
 
      
T A G  83.9 ± 1.1
a
 83.2 ± 1.7
a
 80.3 ± 2.5
b
 80.2 ± 2.8
b
 75.4 ± 1.9
c
 
Sterol  6.0 ± 0.4
bc
 5.6 ± 0.4
c
 6.1 ± 0.7
b
 6.4 ± 0.6
b
 8.3 ± 2.0
a
 
F F A  3.1 ± 0.7
c
 3.0 ± 0.7
c
 3.1 ± 0.7
c
 4.4 ± 0.7
b
 6.6 ± 1.0
a
 
Liver      
P C  13.4 ± 0.4
b
 15.3 ± 2.5
b
 19.5 ± 0.2
a
 18.4 ± 1.5
a
 19.9 ± 2.3
a
 
P E  8.7 ± 0.7
b
 10.8 ± 2.4
b
 13.5 ± 0.7
a
 13.9 ± 0.8
a
 13.4 ± 1.3
a
 
P S  2.4 ± 0.7 2.1 ± 0.0 2.4 ± 0.1 2.8 ± 0.6 2.6 ± 0.4 
P I  5.7 ± 0.2
a
 5.5 ± 0.3
a
 5.4 ± 1.3
a
 4.1 ± 0.5
b
 4.2 ± 0.3
b
 
S M  2.4 ± 0.3
a
 2.2 ± 0.1
a
 2.3 ± 0.2
a
 1.9 ± 0.3
b
 1.9 ± 0.3
b
 
UPL 1.5 ± 0.4
b
 0.6 ± 1.0
b
 1.3 ± 2.3
b
 3.8 ± 0.6
a
 3.4 ± 0.1
a
 
      
Total PL 34.1 ± 1.1
b
 36.4 ± 4.0
b
 44.4 ± 1.4
a
 45.0 ± 3.2
a
 45.7 ± 4.5
a
 
Total NL 65.9 ± 1.1
a
 63.6 ± 4.0
a
 55.6 ± 1.4
b
 56.0 ± 3.2
b
 54.3 ± 4.5
b
 
      
TAG 39.6 ± 1.6
a
 37.2 ± 3.8
ab
 32.4 ± 2.7
bc
 32.1 ± 3.4
bc
 28.8 ± 4.5
c
 
Sterol 9.1 ± 0.4
d
 10.7 ± 1.2
c
 12.7 ± 0.5
b
 12.3 ± 0.7
b
 14.5 ± 1.0
a
 
FFA 1.6 ± 0.3
a
 1.6 ± 0.4
a
 0.5 ± 0.9
b
 1.6 ± 0.6
a
 0.1 ± 0.1
c
 
Steryl ester 15.6 ± 0.3
a
 14.2 ± 1.4
a
 10.1 ± 1.1
b
 9.1 ± 1.0
b
 11.0 ± 1.1
b
 
Results are means ± SD (n = 9). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. DFO, decontaminated northern 
fish oil; FFA, free fatty acid; n.d., not detected; FO, northern fish oil; NL, neutral 
lipids; PC, p hosphatidylcholine; PE, p hosphatidylethanolamine; P I , 
phosphatidylinositol; PL, polar lipids; PS, p hosphatidylserine; SM, sp hingomyelin; 
SRO, southern fish oil and rapeseed oil; SRO/SO, southern fish oil, rapeseed and 
soybean oils; SSO, s outhern fish oil and soybean oil; TAG, triacylglycerol; UPL, 
unidentified polar lipid.  
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Table 8. Fatty acid composition (percentage of total fatty acid) of salmon flesh at the 
end of the feeding trial  
 
 FO DFO SRO SRO/SO SSO 
14:0 4.7 ± 0.2
b
 4.9 ± 0.1
a
 2.9 ± 0.1
c
 2.9 ± 0.1
c
 3.0 ± 0.1
c
 
16:0 17.1 ± 0.6
a
 16.8 ± 0.3
a
 10.9 ± 0.6
d
 12.2 ± 0.4
c
 13.5 ± 0.5
b
 
18:0 2.8 ± 0.1
c
 2.7 ± 0.1
c
 2.7 ± 0.2
c
 3.2 ± 0.1
b
 3.6 ± 0.2
a
 
Total saturated
1
 25.3 ± 0.8
a
 25.1 ± 0.5
a
 17.2 ± 0.8
d
 19.0 ± 0.6
c
 21.1 ± 0.8
b
 
16:1n-7 6.0 ± 0.2
a
 5.8 ± 0.1
a
 2.9 ± 1.4
c
 2.9 ± 1.1
bc
 3.4 ± 0.1
b
 
18:1n-9 25.1 ± 0.6
c
 21.9 ± 0.3
d
 39.0 ± 1.2
a
 28.9 ± 0.4
b
 19.9 ± 0.4
c
 
18:1n-7 3.1 ± 0.2
b
 3.1 ± 0.1
b
 3.3 ± 0.2
a
 3.0 ± 0.2
b
 2.6 ± 0.1
c
 
20:1n-9 2.5 ± 0.1
b
 3.3 ± 0.1
a
 1.9 ± 0.1
c
 1.5 ± 0.1
d
 1.1 ± 0.1
e
 
22:1n11 1.8 ± 0.1
b
 3.1 ± 0.2
a
 0.5 ± 0.1
d
 0.5 ± 0.1
d
 0.6 ± 0.1
c
 
24:1n-9 1.3 ± 0.2
a
 1.2 ± 0.1
b
 0.4 ± 0.0
c
 0.4 ± 0.0
c
 0.4 ± 0.1
c
 
Total monoenes
2
 40.8 ± 0.8
b
 39.3 ± 0.6
c
 49.0 ± 1.1
a
 38.1 ± 0.3
d
 28.6 ± 0.5
e
 
18:2n-6 5.3 ± 0.2
d
 5.8 ± 1.0
d
 11.9 ± 0.3
c
 20.9 ± 0.6
b
 28.1 ± 1.1
a
 
20:4n-6 0.6 ± 0.0
a
 0.6 ± 0.0
a
 0.5 ± 0.0
b
 0.5 ± 0.0
b
 0.5 ± 0.0
b
 
Total n-6 PUFA
3
 7.3 ± 0.3 7.7 ± 1.0 13.8 ± 0.5 23.0 ± 0.6 30.5 ± 1.2 
18:3n-3 2.3 ± 0.1
d
 2.3 ± 0.1
d
 5.6 ± 0.2
a
 4.5 ± 0.2
b
 3.2 ± 0.1
c
 
18:4n-3 1.5 ± 0.1
b
 1.8 ± 0.1
a
 0.8 ± 0.1
d
 0.8 ± 0.0
d
 0.9 ± 0.1
c
 
20:4n-3 1.2 ± 0.1
a
 1.1 ± 0.1
b
 0.7 ± 0.1
c
 0.7 ± 0.0
c
 0.7 ± 0.0
c
 
20:5n-3 5.9 ± 0.4b 6.9 ± 0.3a 4.6 ± 0.4d 4.9 ± 0.1cd 5.2 ± 0.3c 
22:5n-3 2.1 ± 0.2
a
 2.0 ± 0.1
ab
 1.7 ± 0.2
d
 1.8 ± 0.1
cd
 1.9 ± 0.2
bc
 
22:6n-3 13.1 ± 0.6
a
 13.6 ± 0.6
a
 6.4 ± 0.5
c
 6.7 ± 0.2
c
 7.5 ± 0.5
b
 
Total n-3 PUFA
4
 26.6 ± 1.2
b
 28.0 ± 1.0
a
 20.0 ± 1.4
c
 20.0 ± 0.3
c
 19.8 ± 0.8
c
 
Total PUFA 34.0 ± 1.4
d
 35.7 ± 0.7
c
 33.8 ± 1.8
d
 43.0 ± 0.7
b
 50.4 ± 1.1
a
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Includes 15:0, 20:0 and 22:0 at 
up to 0.5%; 
2
Includes 16:1n-9, 20:1n-11, 20:1n-7 and 22:1n-9 at up to 0.6%; 
3
Includes 
18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 at up to 0.9%; 
4
Includes 20:3n-3 at up 
to 0.3%. DFO, decontaminated northern fish oil; FO, northern fish oil; PUFA, 
polyunsaturated fatty acids; SRO, southern fish oil and rapeseed oil; SRO/SO, 
southern fish oil, rapeseed oil and soybean oil; SSO, southern fish oil and soybean oil. 
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Table 9. Fatty acid composition (percentage of total fatty acids) of salmon liver at the 
end of the feeding trial 
 
 FO DFO SRO SRO/SO SSO 
14:0 2.2 ± 0.2
a
 2.2 ± 0.5
a
 1.3 ± 0.4
b
 1.1 ± 0.2
b
 1.1 ± 0.1
b
 
16:0 11.2 ± 1.5
ab
 10.7 ± 1.5
ab
 9.7 ± 2.1
b
 10.7 ± 1.3
ab
 12.1 ± 1.1
a
 
18:0 4.1 ± 0.6
b
 4.0 ± 0.4
b
 4.4 ± 0.5
b
 5.5 ± 0.7
a
 6.0 ± 0.6
a
 
Total saturated
1
 18.0 ± 2.0
ab
  17.4 ± 2.2
ab
 15.9 ± 2.8
b
 17.6 ± 1.4
ab
 19.4 ± 1.6
a
 
16:1n-7 3.7 ± 0.5
a
 3.4 ± 0.7
a
 1.7 ± 0.4
b
 1.3 ± 0.5
b
 1.0 ± 0.8
c
 
18:1n-9 23.1 ± 3.3
b
 24.3 ± 3.8
b
 28.3 ± 5.9
a
 20.7 ± 4.0
b
 15.7 ± 1.8
c
 
18:1n-7 3.8 ± 0.3
a
 3.7 ± 0.3
a
 3.0 ± 0.3
b
 2.6 ± 0.3
c
 2.2 ± 0.2
d
 
20:1n-9 3.3 ± 0.4
ab
 3.6 ± 0.4
a
 3.1 ± 0.5
b
 2.1 ± 0.4
c
 1.4 ± 0.2
d
 
22:1n11 0.9 ± 0.3
a
 1.0 ± 0.5
a
 0.1 ± 0.3
b
 n.d. n.d. 
24:1n-9 0.9 ± 0.1
ab
 1.0 ± 0.2
a
 0.8 ± 0.2
ab
 0.7 ± 0.1
c
 0.7 ± 0.1
c
 
Total monenes
2
 36.7 ± 3.9
a
 38.2 ± 3.3
a
 37.6 ± 5.5
a
 27.8 ± 4.1
b
 21.6 ± 2.5
c
 
18:2n-6 3.6 ± 0.4
d
 4.0 ± 1.7
d
 7.5 ± 2.1
c
 14.1 ± 2.0
b
 17.7 ± 2.4
a
 
20:2n-6 1.1 ± 0.1
c
 1.2 ± 0.3
c
 1.7 ± 0.4
b
 3.2 ± 0.4
a
 3.5 ± 0.4
a
 
20:3n-6 0.4 ± 0.2
bc
 0.3 ± 0.0
c
 0.4 ± 0.1
bc
 0.5 ± 0.1
a
 0.6 ± 0.1
a
 
20:4n-6 1.7 ± 0.4
b
 1.6 ± 0.3
b
 2.0 ± 0.4
a
 2.3 ± 0.3
a
 2.3 ± 0.3
a
 
Total n-6 PUFA
3
 7.3 ± 0.3
c
 7.7 ± 1.9
c
 12.1 ± 2.0
b
 20.5 ± 2.0
a
 24.5 ± 2.2
a
 
18:3n-3 1.6 ± 0.2
c
 1.7 ± 0.6
c
 3.0 ± 0.8
a
 2.4 ± 0.4
a
 1.6 ± 0.6
c
 
20:4n-3 1.9 ± 0.2
a
 1.7 ± 0.4
a
 0.9 ± 0.2
b
 0.8 ± 0.1
c
 0.7 ± 0.1
c
 
20:5n-3 7.7 ± 1.4
b
 7.7 ± 1.1
b
 9.1 ± 0.9
a
 10.0 ± 1.3
a
 9.7 ± 0.9
a
 
22:5n-3 4.3 ± 0.8
a
 3.7 ± 0.7
a
 2.5 ± 0.8
b
 2.7 ± 0.2
b
 2.6 ± 0.2
b
 
22:6n-3 21.5 ± 1.8
a
 20.7 ± 3.0
ab
 17.7 ± 4.6
b
 17.6 ± 2.1
b
 19.1 ± 2.5
ab
 
Total n-3 PUFA
4
 38.1 ± 2.3
a
 36.7 ± 2.8
ab
 34.5 ± 4.5
b
 34.1 ± 3.0
b
 34.5 ±2.9
b
 
Total PUFA 45.4 ± 2.5
c
 44.4 ± 2.0
c
 46.6 ± 2.9
c
 54.6 ± 3.1
b
 59.0 ± 1.3
a
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Includes 15:0, 20:0 and 22:0 at 
up to 0.3%; 
2
Includes 16:1n-9, 20:1n-11, 20:1n-7 and 22:1n-9 at up to 0.6%; 
3
Includes 
18:3n-6, 22:4n-6 and 22:5n-6 at up to 0.4%; 
4
Includes 18:4n-3 and 20:3n-3 at up to 
0.8%. DFO, decontaminated northern fish oil; FO, northern fish oil; PUFA, 
polyunsaturated fatty acids; SRO, southern fish oil and rapeseed oil; SRO/SO, 
southern fish  
